{"id":604240,"date":"2024-06-02T20:00:00","date_gmt":"2024-06-03T00:00:00","guid":{"rendered":"https:\/\/platohealth.ai\/advances-and-challenges-in-modeling-inherited-peripheral-neuropathies-using-ipscs-experimental-molecular-medicine\/"},"modified":"2024-06-03T00:26:24","modified_gmt":"2024-06-03T04:26:24","slug":"advances-and-challenges-in-modeling-inherited-peripheral-neuropathies-using-ipscs-experimental-molecular-medicine","status":"publish","type":"post","link":"https:\/\/platohealth.ai\/advances-and-challenges-in-modeling-inherited-peripheral-neuropathies-using-ipscs-experimental-molecular-medicine\/","title":{"rendered":"Advances and challenges in modeling inherited peripheral neuropathies using iPSCs – Experimental & Molecular Medicine","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"
<\/div>\n
  • \n

    Baets, J., De Jonghe, P. & Timmerman, V. Recent advances in Charcot\u2013Marie\u2013Tooth disease. Curr. Opin. Neurol.<\/i> 27<\/b>, 532\u2013540 (2014).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Pisciotta, C. & Shy, M. E. Neuropathy. Handb. Clin. Neurol<\/i> 148, 653\u2013665 (2018).<\/p>\n<\/li>\n

  • \n

    Saporta, M. A. & Shy, M. E. Inherited peripheral neuropathies. Neurol. Clin.<\/i> 31<\/b>, 597\u2013619 (2013).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Adams, D. et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N. Engl. J. Med.<\/i> 379<\/b>, 11\u201321 (2018).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Benson, M. D. et al. Inotersen treatment for patients with hereditary transthyretin amyloidosis. N. Engl. J. Med.<\/i> 379<\/b>, 22\u201331 (2018).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Passage, E. et al. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat. Med.<\/i> 10<\/b>, 396\u2013401 (2004).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Lewis, R. A. High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A. JAMA Neurol.<\/i> 70<\/b>, 981\u2013987 (2013).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Pareyson, D. et al. Ascorbic acid in Charcot\u2013Marie\u2013Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. Lancet Neurol.<\/i> 10<\/b>, 320\u2013328 (2011).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Verhamme, C. et al. Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial. BMC Med.<\/i> 7<\/b>, 70 (2009).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Burns, J. et al. Ascorbic acid for Charcot\u2013Marie\u2013Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial. Lancet Neurol.<\/i> 8<\/b>, 537\u2013544 (2009).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Garofalo, K. et al. Oral l-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1. J. Clin. Investig.<\/i> 121<\/b>, 4735\u20134745 (2011).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Fridman, V. et al. Randomized trial of l-serine in patients with hereditary sensory and autonomic neuropathy type 1. Neurology<\/i> 92<\/b>, 359 (2019).<\/p>\n

    Article<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Colman, A. Profile of John Gurdon and Shinya Yamanaka, 2012 Nobel Laureates in medicine or physiology. Proc. Natl Acad. Sci. USA<\/i> 110<\/b>, 5740\u20135741 (2013).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Lee, G. et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature<\/i> 461<\/b>, 402\u2013406 (2009).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Saporta, M. A. et al. Axonal Charcot-Marie-Tooth disease patient-derived motor neurons demonstrate disease-specific phenotypes including abnormal electrophysiological properties. Exp. Neurol.<\/i> 263<\/b>, 190\u2013199 (2015).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Harschnitz, O. et al. Autoantibody pathogenicity in a multifocal motor neuropathy induced pluripotent stem cell-derived model. Ann. Neurol.<\/i> 80<\/b>, 71\u201388 (2016).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Perez-Siles, G. et al. Energy metabolism and mitochondrial defects in X-linked Charcot-Marie-Tooth (CMTX6) iPSC-derived motor neurons with the p.R158H PDK3 mutation. Sci. Rep.<\/i> 10<\/b>, 9262 (2020).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Cutrupi, A. N. et al. Novel gene\u2013intergenic fusion involving ubiquitin E3 ligase UBE3C causes distal hereditary motor neuropathy. Brain<\/i> 146<\/b>, 880\u2013897 (2023).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Maury, Y. et al. Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes. Nat. Biotechnol.<\/i> 33<\/b>, 89\u201396 (2015).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Guo, W. et al. HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients. Nat. Commun.<\/i> 8<\/b>, 861 (2017).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Van Lent, J. et al. Induced pluripotent stem cell-derived motor neurons of CMT type 2 patients reveal progressive mitochondrial dysfunction. Brain<\/i> 144<\/b>, 2471\u20132485 (2021).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Faye, P.-A. et al. Optimized protocol to generate spinal motor neuron cells from induced pluripotent stem cells from Charcot Marie Tooth patients. Brain Sci.<\/i> 10<\/b>, 407 (2020).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    LaVaute, T. M. et al. Regulation of neural specification from human embryonic. Stem Cells BMP Fgf. Stem Cells<\/i> 27<\/b>, 1741\u20131749 (2009).<\/p>\n

    CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Miressi, F. et al. GDAP1 involvement in mitochondrial function and oxidative stress, investigated in a Charcot-Marie-Tooth model of hiPSCs-derived motor neurons. Biomedicines<\/i> 9<\/b>, 945 (2021).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Feliciano, C. M. et al. Allele-specific gene editing rescues pathology in a human model of Charcot-Marie-Tooth disease type 2E. Front Cell Dev. Biol.<\/i> 9<\/b>, 723023 (2021).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Limone, F. et al. Efficient generation of lower induced motor neurons by coupling Ngn2 expression with developmental cues. Cell Rep.<\/i> 42<\/b>, 111896 (2023).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Perez-Siles, G. et al. Modelling the pathogenesis of X-linked distal hereditary motor neuropathy using patient-derived iPSCs. Dis. Model Mech.<\/i> 13<\/b>, dmm041541 (2020).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Clark, A. J. et al. An iPSC model of hereditary sensory neuropathy-1 reveals L-serine-responsive deficits in neuronal ganglioside composition and axoglial interactions. Cell Rep. Med.<\/i> 2<\/b>, 100345 (2021).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Romano, R. et al. Alteration of the late endocytic pathway in Charcot\u2013Marie\u2013Tooth type 2B disease. Cell. Mol. Life Sci.<\/i> 78<\/b>, 351\u2013372 (2021).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Chambers, S. M. et al. Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors. Nat. Biotechnol.<\/i> 30<\/b>, 715\u2013720 (2012).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Schrenk-Siemens, K. et al. PIEZO2 is required for mechanotransduction in human stem cell\u2013derived touch receptors. Nat. Neurosci.<\/i> 18<\/b>, 10\u201316 (2015).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Middleton, S. J. et al. Studying human nociceptors: from fundamentals to clinic. Brain<\/i> 144<\/b>, 1312\u20131335 (2021).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Nickolls, A. R. et al. Transcriptional programming of human mechanosensory neuron subtypes from pluripotent stem cells. Cell Rep.<\/i> 30<\/b>, 932\u2013946 (2020).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Alshawaf, A. J. et al. Phenotypic and functional characterization of peripheral sensory neurons derived from human embryonic stem cells. Sci. Rep.<\/i> 8<\/b>, 603 (2018).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Saito-Diaz, K., Street, J. R., Ulrichs, H. & Zeltner, N. Derivation of peripheral nociceptive, mechanoreceptive, and proprioceptive sensory neurons from the same culture of human pluripotent stem cells. Stem Cell Rep.<\/i> 16<\/b>, 446\u2013457 (2021).<\/p>\n

    Article<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Ernsberger, U. Role of neurotrophin signalling in the differentiation of neurons from dorsal root ganglia and sympathetic ganglia. Cell Tissue Res.<\/i> 336<\/b>, 349\u2013384 (2009).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Zeidler, M. et al. NOCICEPTRA: gene and microRNA signatures and their trajectories characterizing human iPSC\u2010derived nociceptor maturation. Adv. Sci.<\/i> 8<\/b>, 2102354 (2021).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Eberhardt, E. et al. Pattern of functional TTX-resistant sodium channels reveals a developmental stage of human iPSC- and ESC-derived nociceptors. Stem Cell Rep.<\/i> 5<\/b>, 305\u2013313 (2015).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Deng, T. et al. Scalable generation of sensory neurons from human pluripotent stem cells. Stem Cell Rep.<\/i> 18<\/b>, 1030\u20131047 (2023).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Oh, Y. et al. Functional coupling with cardiac muscle promotes maturation of hPSC-derived sympathetic neurons. Cell Stem Cell<\/i> 19<\/b>, 95\u2013106 (2016).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Kirino, K., Nakahata, T., Taguchi, T. & Saito, M. K. Efficient derivation of sympathetic neurons from human pluripotent stem cells with a defined condition. Sci. Rep.<\/i> 8<\/b>, 12865 (2018).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Frith, T. J. et al. Human axial progenitors generate trunk neural crest cells in vitro. Elife<\/i> 7<\/b>, e35786 (2018).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Wu, H.-F. et al. Norepinephrine transporter defects lead to sympathetic hyperactivity in Familial Dysautonomia models. Nat. Commun.<\/i> 13<\/b>, 7032 (2022).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Wu, H.-F. et al. Parasympathetic neurons derived from human pluripotent stem cells model human diseases and development. Cell Stem Cell. S1934\u20135909<\/b>, 00092\u20134. https:\/\/pubmed.ncbi.nlm.nih.gov\/38608707\/<\/a> (2024) Online ahead of print.<\/p>\n<\/li>\n

  • \n

    Muhammad, A. et al. Cell transplantation strategies for acquired and inherited disorders of peripheral myelin. Ann. Clin. Transl. Neurol.<\/i> 5<\/b>, 186\u2013200 (2018).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Huang, Z., Powell, R., Kankowski, S., Phillips, J. B. & Haastert-Talini, K. Culture conditions for human induced pluripotent stem cell-derived Schwann cells: a two-centre study. Int. J. Mol. Sci.<\/i> 24<\/b>, 5366 (2023).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Majd, H. et al. Deriving Schwann cells from hPSCs enables disease modeling and drug discovery for diabetic peripheral neuropathy. Cell Stem Cell<\/i> 30<\/b>, 632\u2013647 (2023).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Kim, H.-S., Kim, J. Y., Song, C. L., Jeong, J. E. & Cho, Y. S. Directly induced human Schwann cell precursors as a valuable source of Schwann cells. Stem Cell Res. Ther.<\/i> 11<\/b>, 257 (2020).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Kim, H.-S. et al. Schwann cell precursors from human pluripotent stem cells as a potential therapeutic target for Myelin repair. Stem Cell Rep.<\/i> 8<\/b>, 1714\u20131726 (2017).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Mukherjee-Clavin, B. et al. Comparison of three congruent patient-specific cell types for the modelling of a human genetic Schwann-cell disorder. Nat. Biomed. Eng.<\/i> 3<\/b>, 571\u2013582 (2019).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Prior, R. et al. Defective Schwann cell lipid metabolism alters plasma membrane dynamics in Charcot-Marie-Tooth disease 1A. Preprint at bioRxiv<\/i> https:\/\/doi.org\/10.1101\/2023.04.02.535224<\/a> (2023).<\/p>\n<\/li>\n

  • \n

    Adameyko, I. et al. Schwann cell precursors from nerve innervation are a cellular origin of melanocytes in skin. Cell<\/i> 139<\/b>, 366\u2013379 (2009).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Paratore, C., Goerich, D. E., Suter, U., Wegner, M. & Sommer, L. Survival and glial fate acquisition of neural crest cells are regulated by an interplay between the transcription factor Sox10 and extrinsic combinatorial signaling. Development<\/i> 128<\/b>, 3949\u20133961 (2001).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Britsch, S. et al. The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev.<\/i> 15<\/b>, 66\u201378 (2001).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Dyachuk, V. et al. Parasympathetic neurons originate from nerve-associated peripheral glial progenitors. Science<\/i> 345<\/b>, 82\u201387 (2014).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Kastriti, M. E. et al. Schwann cell precursors represent a neural crest\u2010like state with biased multipotency. EMBO J.<\/i> 41<\/b>, 108780 (2022).<\/p>\n

    Article<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Xie, M. et al. Schwann cell precursors contribute to skeletal formation during embryonic development in mice and zebrafish. Proc. Natl Acad. Sci. USA<\/i> 116<\/b>, 15068\u201315073 (2019).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Jessen, K. R. & Mirsky, R. Schwann cell precursors; multipotent glial cells in embryonic nerves. Front. Mol. Neurosci.<\/i> 12<\/b>, 69 (2019).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Jessen, K. R. & Mirsky, R. The origin and development of glial cells in peripheral nerves. Nat. Rev. Neurosci.<\/i> 6<\/b>, 671\u2013682 (2005).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Stassart, R. M. & Woodhoo, A. Axo\u2010glial interaction in the injured PNS. Dev. Neurobiol.<\/i> 81<\/b>, 490\u2013506 (2021).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Nitzan, E., Pfaltzgraff, E. R., Labosky, P. A. & Kalcheim, C. Neural crest and Schwann cell progenitor-derived melanocytes are two spatially segregated populations similarly regulated by Foxd3. Proc. Natl Acad. Sci. USA<\/i> 110<\/b>, 12709\u201312714 (2013).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Van Raamsdonk, C. D. & Deo, M. Links between Schwann cells and melanocytes in development and disease. Pigment Cell Melanoma Res.<\/i> 26<\/b>, 634\u2013645 (2013).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Colombo, S. et al. Stabilization of \u03b2-catenin promotes melanocyte specification at the expense of the Schwann cell lineage. Development<\/i> 149<\/b>, dev194407 (2022).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Marathe, H. G. et al. BRG1 interacts with SOX10 to establish the melanocyte lineage and to promote differentiation. Nucleic Acids Res.<\/i> 45<\/b>, 6442\u20136458 (2017).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Slutsky, S. G., Kamaraju, A. K., Levy, A. M., Chebath, J. & Revel, M. Activation of Myelin genes during transdifferentiation from melanoma to glial cell phenotype. J. Biol. Chem.<\/i> 278<\/b>, 8960\u20138968 (2003).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Rambow, F. et al. New functional signatures for understanding melanoma biology from tumor cell lineage-specific analysis. Cell Rep.<\/i> 13<\/b>, 840\u2013853 (2015).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Smith, A. et al. HDAC6 inhibition corrects electrophysiological and axonal transport deficits in a human stem cell\u2010based model of Charcot\u2010Marie\u2010Tooth disease (type 2D). Adv. Biol.<\/i> 6<\/b>, 2101308 (2022).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Kennerson, M. L. et al. Missense mutations in the copper transporter gene ATP7A cause X-linked distal hereditary motor neuropathy. Am. J. Hum. Genet.<\/i> 86<\/b>, 343\u2013352 (2010).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Zhu, Y. et al. Sorbitol reduction via govorestat ameliorates synaptic dysfunction and neurodegeneration in sorbitol dehydrogenase deficiency. JCI Insight<\/i> 8<\/b>, e164954 (2023).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    McDermott, L. A. et al. Defining the functional role of NaV1.7 in human nociception. Neuron<\/i> 101<\/b>, 905\u2013919 (2019).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Haidar, M. et al. Neuropathy-causing mutations in HSPB1 impair autophagy by disturbing the formation of SQSTM1\/p62 bodies. Autophagy<\/i> 15<\/b>, 1051\u20131068 (2019).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Alderson, T. R. et al. A weakened interface in the P182L variant of HSP27 associated with severe Charcot-Marie-Tooth neuropathy causes aberrant binding to interacting proteins. EMBO J.<\/i> 40<\/b>, 103811 (2021).<\/p>\n

    Article<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Maciel, R., Correa, R., Bosso Taniguchi, J., Prufer Araujo, I. & Saporta, M. A. Human tridimensional neuronal cultures for phenotypic drug screening in inherited peripheral neuropathies. Clin. Pharm. Ther.<\/i> 107<\/b>, 1231\u20131239 (2020).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Kenvin, S. et al. Threshold of heteroplasmic truncating MT-ATP6 mutation in reprogramming, Notch hyperactivation and motor neuron metabolism. Hum. Mol. Genet.<\/i> 31<\/b>, 958\u2013974 (2022).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Carri\u00f3, M. et al. Reprogramming captures the genetic and tumorigenic properties of neurofibromatosis type 1 plexiform neurofibromas. Stem Cell Rep.<\/i> 12<\/b>, 411\u2013426 (2019).<\/p>\n

    Article<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Cutrupi, A. N., Brewer, M. H., Nicholson, G. A. & Kennerson, M. L. Structural variations causing inherited peripheral neuropathies: a paradigm for understanding genomic organization, chromatin interactions, and gene dysregulation. Mol. Genet. Genom. Med.<\/i> 6<\/b>, 422\u2013433 (2018).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Sudmant, P. H. et al. An integrated map of structural variation in 2,504 human genomes. Nature<\/i> 526<\/b>, 75\u201381 (2015).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Drew, A. P., Cutrupi, A. N., Brewer, M. H., Nicholson, G. A. & Kennerson, M. L. A 1.35\u2009Mb DNA fragment is inserted into the DHMN1 locus on chromosome 7q34\u2013q36.2. Hum. Genet.<\/i> 135<\/b>, 1269\u20131278 (2016).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Brewer, M. H. et al. Whole genome sequencing identifies a 78\u2009kb insertion from chromosome 8 as the cause of Charcot-Marie-Tooth neuropathy CMTX3. PLoS Genet.<\/i> 12<\/b>, 1006177 (2016).<\/p>\n

    Article<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    D’ydewalle, C. et al. HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease. Nat. Med.<\/i> 17<\/b>, 968\u2013974 (2011).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Kalmar, B. et al. Mitochondrial deficits and abnormal mitochondrial retrograde axonal transport play a role in the pathogenesis of mutant Hsp27-induced Charcot Marie Tooth disease. Hum. Mol. Genet.<\/i> 26<\/b>, 3313\u20133326 (2017).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Baloh, R. H., Schmidt, R. E., Pestronk, A. & Milbrandt, J. Altered Axonal Mitochondrial Transport In The Pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations. J. Neurosci.<\/i> 27<\/b>, 422\u2013430 (2007).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Alecu, I. et al. Localization of 1-deoxysphingolipids to mitochondria induces mitochondrial dysfunction. J. Lipid Res.<\/i> 58<\/b>, 42\u201359 (2017).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Adriaenssens, E. et al. Small heat shock proteins operate as molecular chaperones in the mitochondrial intermembrane space. Nat. Cell Biol.<\/i> 25<\/b>, 467\u2013480 (2023).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Hagemann, C. et al. Axonal length determines distinct homeostatic phenotypes in human iPSC derived motor neurons on a bioengineered platform. Adv. Health. Mater.<\/i> 11<\/b>, 2101817 (2022).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Butler, L. et al. HDAC6 inhibition partially alleviates mitochondrial trafficking defects and restores motor function in human motor neuron and zebrafish models of Charcot-Marie-Tooth disease type 2\u2009A. Preprint at bioRxiv<\/i> https:\/\/doi.org\/10.1101\/2022.07.05.498819<\/a> (2022).<\/p>\n<\/li>\n

  • \n

    Pal, A. et al. High content organelle trafficking enables disease state profiling as powerful tool for disease modelling. Sci. Data<\/i> 5<\/b>, 180241 (2018).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Nijssen, J., Aguila, J., Hoogstraaten, R., Kee, N. & Hedlund, E. Axon-Seq decodes the motor axon transcriptome and its modulation in response to ALS. Stem Cell Rep.<\/i> 11<\/b>, 1565\u20131578 (2018).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Badiola-Mateos, M., Osaki, T., Kamm, R. D. & Samitier, J. In vitro modelling of human proprioceptive sensory neurons in the neuromuscular system. Sci. Rep.<\/i> 12<\/b>, 21318 (2022).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Monje, P. V., Sant, D. & Wang, G. Phenotypic and functional characteristics of human Schwann cells as revealed by cell-based assays and RNA-SEQ. Mol. Neurobiol.<\/i> 55<\/b>, 6637\u20136660 (2018).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Clark, A. J. et al. Co-cultures with stem cell-derived human sensory neurons reveal regulators of peripheral myelination. Brain<\/i> 140<\/b>, 898\u2013913 (2017).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Sharma, A. D. et al. Engineering a 3D functional human peripheral nerve in vitro using the Nerve-on-a-Chip platform. Sci. Rep.<\/i> 9<\/b>, 8921 (2019).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Louit, A., Beaudet, M.-J., P\u00e9pin, R. & Berthod, F. Differentiation of human induced pluripotent stem cells into mature and myelinating Schwann cells. Tissue Eng. Part C. Methods<\/i> 29<\/b>, 134\u2013143 (2023).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Sabblah, T. T. et al. A novel mouse model carrying a human cytoplasmic dynein mutation shows motor behavior deficits consistent with Charcot-Marie-Tooth type 2\u2009O disease. Sci. Rep.<\/i> 8<\/b>, 1739 (2018).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Ang, E.-T. et al. Motor axonal sprouting and neuromuscular junction loss in an animal model of Charcot-Marie-Tooth disease. J. Neuropathol. Exp. Neurol.<\/i> 69<\/b>, 281\u2013293 (2010).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Sleigh, J. N., Grice, S. J., Burgess, R. W., Talbot, K. & Cader, M. Z. Neuromuscular junction maturation defects precede impaired lower motor neuron connectivity in Charcot-Marie-Tooth type 2D mice. Hum. Mol. Genet.<\/i> 23<\/b>, 2639\u20132650 (2014).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Jones, R. A. et al. Cellular and molecular anatomy of the human neuromuscular junction. Cell Rep.<\/i> 21<\/b>, 2348\u20132356 (2017).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Stoklund Dittlau, K. et al. Human motor units in microfluidic devices are impaired by FUS mutations and improved by HDAC6 inhibition. Stem Cell Rep.<\/i> 16<\/b>, 2213\u20132227 (2021).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Stoklund Dittlau, K. et al. FUS-ALS hiPSC-derived astrocytes impair human motor units through both gain-of-toxicity and loss-of-support mechanisms. Mol. Neurodegener.<\/i> 18<\/b>, 5 (2023).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Rose, N. et al. Receptor clustering and pathogenic complement activation in myasthenia gravis depend on synergy between antibodies with multiple subunit specificities. Acta Neuropathol.<\/i> 144<\/b>, 1005\u20131025 (2022).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Sleigh, J. N. et al. Boosting peripheral BDNF rescues impaired in vivo axonal transport in CMT2D mice. JCI Insight<\/i> 8<\/b>, e157191 (2023).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Amin, N. D. & Pa\u015fca, S. P. Building models of brain disorders with three-dimensional organoids. Neuron<\/i> 100<\/b>, 389\u2013405 (2018).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Lancaster, M. A. et al. Cerebral organoids model human brain development and microcephaly. Nature<\/i> 501<\/b>, 373\u2013379 (2013).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    James, O. G. et al. iPSC-derived myelinoids to study myelin biology of humans. Dev. Cell<\/i> 56<\/b>, 1346\u20131358 (2021).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Pereira, J. D. et al. Human sensorimotor organoids derived from healthy and amyotrophic lateral sclerosis stem cells form neuromuscular junctions. Nat. Commun.<\/i> 12<\/b>, 4744 (2021).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Van Lent, J. et al. Downregulation of PMP22 ameliorates myelin defects in iPSC-derived human organoid cultures of CMT1A. Brain<\/i> 146<\/b>, 2885\u20132896 (2023).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Faustino Martins, J. M. et al. Self-organizing 3D human trunk neuromuscular organoids. Cell Stem Cell<\/i> 26<\/b>, 172\u2013186 (2020).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Rockel, A. F., Wagner, N., Spenger, P., Erg\u00fcn, S. & W\u00f6rsd\u00f6rfer, P. Neuro-mesodermal assembloids recapitulate aspects of peripheral nervous system development in vitro. Stem Cell Rep.<\/i> 18<\/b>, 1155\u20131165 (2023).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Lischka, A. et al. Genetic pain loss disorders. Nat. Rev. Dis. Prim.<\/i> 8<\/b>, 41 (2022).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Rousi, E. et al. An innervated skin 3D in vitro model for dermatological research. Vitr. Models<\/i> 2<\/b>, 113\u2013121 (2022).<\/p>\n

    Article<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Muller, Q. et al. Development of an innervated tissue-engineered skin with human sensory neurons and Schwann cells differentiated from iPS cells. Acta Biomater.<\/i> 82<\/b>, 93\u2013101 (2018).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Juneja, M. et al. PFN2 and GAMT as common molecular determinants of axonal Charcot-Marie-Tooth disease. J. Neurol. Neurosurg. Psychiatry<\/i> 89<\/b>, 870\u2013878 (2018).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Jennings, M. J. et al. NCAM1 and GDF15 are biomarkers of Charcot-Marie-Tooth disease in patients and mice. Brain<\/i> 145<\/b>, 3999\u20134015 (2022).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Mart\u00ednez-Muriana, A. et al. CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nerves. Sci. Rep.<\/i> 6<\/b>, 25663 (2016).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Chiu, I. M. et al. Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. Proc. Natl Acad. Sci. USA<\/i> 106<\/b>, 20960\u201320965 (2009).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Klein, D. et al. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot\u2013Marie\u2013Tooth disease in mice. Brain<\/i> 138<\/b>, 3193\u20133205 (2015).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Klein, D. et al. Early targeting of endoneurial macrophages alleviates the neuropathy and affects abnormal Schwann cell differentiation in a mouse model of Charcot\u2010Marie\u2010Tooth 1A. Glia<\/i> 70<\/b>, 1100\u20131116 (2022).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Gomez-Sanchez, J. A. et al. Schwann cell autophagy, myelinophagy, initiates myelin clearance from injured nerves. J. Cell Biol.<\/i> 210<\/b>, 153\u2013168 (2015).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Park, H. T., Kim, J. K. & Tricaud, N. The conceptual introduction of the \u201cdemyelinating Schwann cell\u201d in peripheral demyelinating neuropathies. Glia<\/i> 67<\/b>, 571\u2013581 (2019).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Jang, S. Y. et al. Schwann cell dedifferentiation-associated demyelination leads to exocytotic myelin clearance in inflammatory segmental demyelination. Glia<\/i> 65<\/b>, 1848\u20131862 (2017).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Wei\u00df, E. M., Geldermann, M., Martini, R. & Klein, D. Macrophages influence Schwann cell myelin autophagy after nerve injury and in a model of Charcot\u2010Marie\u2010Tooth disease. J. Peripher. Nerv. Syst.<\/i> 28<\/b>, 341\u2013350 (2023).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Vital, A., Vital, C., Julien, J. & Fontan, D. Occurrence of active demyelinating lesions in children with hereditary motor and sensory neuropathy (HMSN) type I. Acta Neuropathol.<\/i> 84<\/b>, 433\u2013436 (1992).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Martini, R. & Toyka, K. V. Immune-mediated components of hereditary demyelinating neuropathies: lessons from animal models and patients. Lancet Neurol.<\/i> 3<\/b>, 457\u2013465 (2004).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Ginsberg, L. Coexistent hereditary and inflammatory neuropathy. Brain<\/i> 127<\/b>, 193\u2013202 (2004).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Malandrini, A., Villanova, M., Dotti, M. T. & Federico, A. Acute inflammatory neuropathy in Charcot-Marie-Tooth disease. Neurology<\/i> 52<\/b>, 859\u2013861 (1999).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Fernandez-Lizarbe, S. et al. Neuroinflammation in the pathogenesis of axonal Charcot-Marie-Tooth disease caused by lack of GDAP1. Exp. Neurol.<\/i> 320<\/b>, 113004 (2019).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Le\u00f3n, M. et al. Rapid degeneration of iPSC-derived motor neurons lacking Gdap1 engages a mitochondrial-sustained innate immune response. Cell Death Discov.<\/i> 9<\/b>, 217 (2023).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Yu, C.-H. et al. TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS\/STING in ALS. Cell<\/i> 183<\/b>, 636\u2013649 (2020).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Kim, J., Kim, H.-S. & Chung, J. H. Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STING pathway. Exp. Mol. Med.<\/i> 55<\/b>, 510\u2013519 (2023).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Vatine, G. D. et al. Human iPSC-derived blood-brain barrier chips enable disease modeling and personalized medicine applications. Cell Stem Cell<\/i> 24<\/b>, 995\u20131005 (2019).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Kilpinen, H. et al. Common genetic variation drives molecular heterogeneity in human iPSCs. Nature<\/i> 546<\/b>, 686 (2017).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Pantazis, C. B. et al. A reference human induced pluripotent stem cell line for large-scale collaborative studies. Cell Stem Cell<\/i> 29<\/b>, 1685\u20131702 (2022).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Boczonadi, V. et al. Mutations in glycyl-tRNA synthetase impair mitochondrial metabolism in neurons. Hum. Mol. Genet.<\/i> 27<\/b>, 2187\u20132204 (2018).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Franco, A. et al. Burst mitofusin activation reverses neuromuscular dysfunction in murine CMT2A. Elife<\/i> 9<\/b>, e61119 (2020).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Wainger, B. J. et al. Modeling pain in vitro using nociceptor neurons reprogrammed from fibroblasts. Nat. Neurosci.<\/i> 18<\/b>, 17\u201324 (2015).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Sanen, K. et al. Engineered neural tissue with Schwann cell differentiated human dental pulp stem cells: potential for peripheral nerve repair? J. Tissue Eng. Regen. Med.<\/i> 11<\/b>, 3362\u20133372 (2017).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Martens, W. et al. Human dental pulp stem cells can differentiate into Schwann cells and promote and guide neurite outgrowth in an aligned tissue\u2010engineered collagen construct in vitro. FASEB J.<\/i> 28<\/b>, 1634\u20131643 (2014).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Wadman, M. FDA no longer has to require animal testing for new drugs. Science<\/i> 379<\/b>, 127\u2013128 (2023).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Imamura, K. et al. The Src\/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis. Sci. Transl. Med<\/i> 9<\/b>, eaaf3962 (2017).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Osaki, T., Uzel, S. & Kamm, R. D. Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons. Sci. Adv.<\/i> 4<\/b>, 5847 (2018).<\/p>\n

    Article<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Imamura, K. et al. Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): A multicentre, open-label, dose-escalation phase 1 trial. EClinicalMedicine<\/i> 53<\/b>, 101707 (2022).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Morimoto, S. et al. Phase 1\/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery. Cell Stem Cell<\/i> 30<\/b>, 766\u2013780 (2023).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Rocha, A. G. et al. MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2. Science<\/i> 360<\/b>, 336\u2013341 (2018).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Varkuti, B. H. et al. Neuron-based high-content assay and screen for CNS active mitotherapeutics. Sci. Adv.<\/i> 6<\/b>, 8702 (2020).<\/p>\n

    Article<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Shlevkov, E. et al. A high-content screen identifies TPP1 and Aurora B as regulators of axonal mitochondrial transport. Cell Rep.<\/i> 28<\/b>, 3224\u20133237 (2019).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Kim, J.-Y. et al. HDAC6 inhibitors rescued the defective axonal mitochondrial movement in motor neurons derived from the induced pluripotent stem cells of peripheral neuropathy patients with HSPB1 mutation. Stem Cells Int.<\/i> 2016<\/b>, 1\u201314 (2016).<\/p>\n


    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Chumakov, I. et al. Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy. Orphanet J. Rare Dis.<\/i> 9<\/b>, 201 (2014).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Prukop, T. et al. Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A). PLoS ONE<\/i> 14<\/b>, 0209752 (2019).<\/p>\n

    Article<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Thenmozhi, R., Lee, J.-S., Park, N. Y., Choi, B.-O. & Hong, Y. B. Gene therapy options as new treatment for inherited peripheral neuropathy. Exp. Neurobiol.<\/i> 29<\/b>, 177\u2013188 (2020).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Mercuri, E. et al. Nusinersen versus sham control in later-onset spinal muscular atrophy. N. Engl. J. Med.<\/i> 378<\/b>, 625\u2013635 (2018).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Rizzo, F. et al. Combined RNA interference and gene replacement therapy targeting MFN2 for the treatment of Charcot-Marie-Tooth type 2 A. Cell Mol Life Sci.<\/i> 80<\/b>, 373 (2023).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Bouhy, D. et al. A knock-in\/knock-out mouse model of HSPB8-associated distal hereditary motor neuropathy and myopathy reveals toxic gain-of-function of mutant Hspb8. Acta Neuropathol.<\/i> 135<\/b>, 131\u2013148 (2018).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Kammoun, M. et al. The invalidation of HspB1 gene in mouse alters the ultrastructural phenotype of muscles. PLoS ONE<\/i> 11<\/b>, e0158644 (2016).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Huang, L., Min, J.-N., Masters, S., Mivechi, N. F. & Moskophidis, D. Insights into function and regulation of small heat shock protein 25 (HSPB1) in a mouse model with targeted gene disruption. Genesis<\/i> 45<\/b>, 487\u2013501 (2007).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Baylot, V. et al. Targeting TCTP as a new therapeutic strategy in castration-resistant prostate cancer. Mol. Ther.<\/i> 20<\/b>, 2244\u20132256 (2012).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Tuma, J. et al. Lipid nanoparticles deliver mRNA to the brain after an intracerebral injection. Biochemistry<\/i> 62<\/b>, 3533\u20133547 (2023).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Stahl, E. C. et al. Genome editing in the mouse brain with minimally immunogenic Cas9 RNPs. Mol. Ther.<\/i> 31<\/b>, 2422\u20132438 (2023).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Hu, B.Y. & Zhang, S.C. Differentiation of spinal motor neurons from pluripotent human stem cells. Nat Protoc.<\/i> 4<\/b>, 1295\u20131304 (2009).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Reinhardt, P. et al. Derivation and expansion using only small molecules of human neural progenitors for neurodegenerative disease modeling. PLoS One.<\/i> 8<\/b>, e59252 (2013).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Amoroso, M.W. et al. Accelerated high-yield generation of limb-innervating motor neuronsfrom human stem cells. J Neurosci.<\/i> 33<\/b>, 574\u2013586 (2013).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Fernandopulle, M.S. et al. Transcription Factor-Mediated Differentiation of Human iPSCs into Neurons. Curr Protoc Cell Biol.<\/i> 79<\/b>, e51 (2018).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Shi, L. et al. Modeling the Pathogenesis of Charcot-Marie-Tooth Disease Type 1A Using Patient-Specific iPSCs. Stem Cell Reports.<\/i> 10<\/b>, 120\u2013133 (2018).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Kitani-Morii, F. et al. Analysis of neural crest cells from Charcot-Marie-Tooth disease patients demonstrates disease-relevant molecular signature. Neuroreport<\/i> 28<\/b>, 814\u2013821 (2017).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Sainio, M.T. et al. Absence of NEFL in patient-specific neurons in early-onset Charcot-Marie-Tooth neuropathy. Neurol Genet<\/i> 4<\/b>, e244 (2018).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Sainio, M.T. et al. Neurofilament Light Regulates Axon Caliber, Synaptic Activity, and Organelle Trafficking in Cultured Human Motor Neurons. Front Cell Dev Biol<\/i> 9<\/b>, 820105 (2022).<\/p>\n

    Article<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Rizzo, F. et al. Selective mitochondrial depletion, apoptosis resistance, and increased mitophagy in human Charcot-Marie-Tooth 2A motor neurons. Hum Mol Genet<\/i> 25<\/b>, 4266\u20134281 (2016).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Smith, A.S.T. et al. HDAC6 Inhibition Corrects Electrophysiological and Axonal Transport Deficits in a Human Stem Cell-Based Model of Charcot-Marie-Tooth Disease (Type 2D). Adv Biol<\/i> 6<\/b>, e2101308 (2021).<\/p>\n

    Article<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Wolf, C. et al. GDAP1 loss of function inhibits the mitochondrial pyruvate dehydrogenase complex by altering the actin cytoskeleton. Commun Biol<\/i> 5<\/b>, 541 (2022).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Lee, G. et al. Large-scale screening using familial dysautonomia induced pluripotent stem cells identifies compounds that rescue IKBKAP expression. Nat Biotechnol.<\/i> 30<\/b>, 1244\u20131248 (2012).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Zeltner, N. et al. Capturing the biology of disease severity in a PSC-based model of familial dysautonomia. Nat Med<\/i> 22<\/b>, 1421\u20131427 (2016).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n

  • \n

    Ajiro, M. et al. Therapeutic manipulation of IKBKAP mis-splicing with a small molecule to cure familial dysautonomia. Nat Commun.<\/i> 12<\/b>, 4507 (2021).<\/p>\n

    Article<\/a> 
    \n     CAS<\/a> 
    \n     PubMed<\/a> 
    \n     PubMed Central<\/a> 
    \n
    \n Google Scholar<\/a> \n <\/p>\n<\/li>\n